Camden Capital »

Novo Nordisk A/S shares owned by Camden Capital

Quarter-by-quarter ownership of Novo Nordisk A/S (NVO) shares owned by Camden Capital from 13F filings

Historical chart of Camden Capital investment in Novo Nordisk A/S

Tip: Access up to 7 years of quarterly data

All positions including Novo Nordisk A/S held by Camden Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novo Nordisk A/S by Camden Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $257k 2.4k 108.63
2021-12-31 $208k 1.9k 112.07

More positions owned by Camden Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Wisdomtree Tr Floatng Rat Trea (USFR)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Exxon Mobil Corporation (XOM)
General Electric Com New (GE)
New York Community Ban (NYCB)
Citigroup Com New (C)
Micron Technology (MU)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core S&p500 Etf (IVV)
Morgan Stanley Com New (MS)
Chevron Corporation (CVX)
Bank of America Corporation (BAC)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)

View all positions for Camden Capital

Top funds holding Novo Nordisk A/S

Jennison Associates
Fisher Investments
Bank of America Corporation
Fayez Sarofim & Co
Folketrygdfondet
Polen Capital Management
T. Rowe Price Associates
Everett Harris & Co
State Farm Mutual Automobile Insurance Company
Goldman Sachs Group
Jpmorgan Chase & Co
WCM Investment Management
Wells Fargo & Company
Sustainable Growth Advisers
Royal Bank of Canada

View all funds holding Novo Nordisk A/S